<DOC>
	<DOCNO>NCT00131326</DOCNO>
	<brief_summary>This clinical study investigate safety efficacy Synvisc Depo-Medrol treat patient osteoarthritis ( OA ) hip .</brief_summary>
	<brief_title>A Study Safety Efficacy Synvisc Depo-Medrol Patients With Osteoarthritis Hip</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Hip</mesh_term>
	<mesh_term>Musculoskeletal Diseases</mesh_term>
	<mesh_term>Hylan</mesh_term>
	<criteria>Patients symptomatic osteoarthritis pain hip Patients current prior condition treatment would impede measurement efficacy safety</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>osteoarthritis hip</keyword>
	<keyword>Musculoskeletal Diseases</keyword>
</DOC>